文档介绍：艾司西瞰普兰与阿普畔仑治疗社交恐惧症的疗效和安全性doi:.1007-:探讨艾司西駄普兰与阿普呼仑治疗社交恐惧症的疗效和安全性。方法:将67例社交恐惧症患者随机分为艾司西瞰普兰组及阿普哩仑组,疗程均12周。疗效评定采用Liebowitz社交焦虑量表(LSAS)及汉密尔顿焦虑量表(HAMA),临床四级疗效评定,以不良反应量表(TESS)评定不良反应。结果:治疗12周后,%,%;%,%,两组疗效差异无统计学意义(卩>0・05),艾司西瞅普兰组不良反应少于阿普哩仑组。结论:艾司西駄普兰治疗社交恐惧症疗效肯定且比阿普哩仑不良反应少。 关键词艾司西駄普兰阿普畔仑社交恐惧症对照研究 TheeffectandsafetyofescitalopramandalprazolaminthetreatmentofsocialphobiaZhengMeiTheHealthSchoolofDonggangDistrict,RizhaoCity,Shandong276826AbstractObjective::67caseswithsocialphobiawererandomlydividedintotheescitalopramgroupandalprazolamgroup・Thecourseoftreatmentwasal112weeks・Weassessedthetherapeuticeffectwith1iebowitzsocialanxietyscale(LSAS)andhamiltonanxietyscale(HAMA),andevaluatedtheadversereactionswithsideeffectsseale(TESS)・Results:After12weeksoftreatment,%,%.Tnalprazolamgroup,%,%.Therewasnosignificantdiffereneebetweenthetwogroups(P>).:Theeffectofescitalopraminthetreatmentofsocialphobiaisgood,anditsadversereactionislessthanalprazolam・ KeywordsEscitalopram;Alprazolam;Socialphobia;Controlstudy社交恐惧症(socialphobia,SP)乂称社交焦虑障碍,是一种高发于青春期、